Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
S

ASH 2019 Updates on Large Cell Lymphoma: Use of ClonoSEQ in Diagnosis, PET-Directed Therapy in Limited-Stage DLBCL, Burkitt Lymphoma Treatment Options & MATRIX-RICE followed by ASCT for CNS Lymphoma

By Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient FEATURING Sunita D. Nasta
By Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient FEATURING Sunita D. Nasta
52 views
February 25, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Recommended

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.4K views

·

8 months ago
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

549 views

·

4 months ago
22:09

New Updates in Frontline DLBCL

Scripps Health

L. Nastoupil

702 views

·

7 months ago
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

648 views

·

6 months ago
16:16

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

384 views

·

4 months ago
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

613 views

·

5 months ago
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

898 views

·

10 months ago
35:27

Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

696 views

·

8 months ago
04:04

Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial

Wojciech Jurczak

343 views

·

4 months ago
10:04

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

Tara Graff

477 views

·

8 months ago
08:01

Treatment Landscape in 1L DLBCL: Polatuzumab Vedotin as SoC

Georg Lenz

287 views

·

4 months ago
30:07

Current Management of DLBCL From Frontline to Relapsed Disease

Dipenkumar Modi

325 views

·

5 months ago
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

302 views

·

5 months ago
35:24

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

SOHO Highlights: State of the Art and Next Questions

G. Nowakowski

394 views

·

7 months ago
33:48

State of the Art and Next Questions: B-Cell Lymphoma

SOHO Highlights: State of the Art and Next Questions

L. Nastoupil

428 views

·

7 months ago
34:36

Frontline DLBCL Treatment Approaches

MyCancerHaven

R. Vij, H. Cherng

313 views

·

6 months ago
22:35

New

Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL

Yale Cancer Center

T. Sethi

147 views

·

3 weeks ago
04:29

Polatuzumab Vedotin in 1L DLBCL: Perspectives on the POLARIX Trial

Juan Pablo Alderuccio

227 views

·

4 months ago
40:38

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

244 views

·

3 months ago
62:02

New Treatment Strategies in DLBCL

UChicago Medicine

L. Sehn

1.1K views

·

1 year ago
AUTOPLAY